The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
NF-κB in cancer: from innocent bystander to major culprit
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Self-citationNuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
Self-citationInterleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,274
Greenlee, R. T., Murray, T., Bolden, S., & Wingo, P. A. (2000) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.1.7 · Cited by 3,850
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
NF-κB at the crossroads of life and death
Karin, M., & Lin, A. (2002) · Nature Immunology · doi:10.1038/ni0302-221 · Cited by 2,709
Self-citationTNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., & Dubois, R. N. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90246-1 · Cited by 2,514
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
El-Omar, E. M., Carrington, M., Chow, W.-H., McColl, K. E. L., Bream, J. H., Young, H. A., Herrera, J., Lissowska, J., Yuan, C.-C., Rothman, N., et al. (2000) · Nature · doi:10.1038/35006081 · Cited by 2,366
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Interleukin-8 as a macrophage-derived mediator of angiogenesis
Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., & Strieter, R. M. (1992) · Science · doi:10.1126/science.1281554 · Cited by 2,135
Liu, Z.-G., Hsu, H., Goeddel, D. V., & Karin, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81375-6 · Cited by 1,937
Self-citationHelicobacter pylori and gastrointestinal tract adenocarcinomas
Peek, R. M., & Blaser, M. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc703 · Cited by 1,813
Aspirin Use and Reduced Risk of Fatal Colon Cancer
Thun, M. J., Namboodiri, M. M., & Heath, C. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252301 · Cited by 1,673
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
Yin, M.-J., Yamamoto, Y., & Gaynor, R. B. (1998) · Nature · doi:10.1038/23948 · Cited by 1,590
Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway
Senftleben, U., Cao, Y., Xiao, G., Greten, F. R., Krähn, G., Bonizzi, G., Chen, Y., Hu, Y., Fong, A., Sun, S.-C., et al. (2001) · Science · doi:10.1126/science.1062677 · Cited by 1,359
Self-citationNF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
Cyclin D1 provides a link between development and oncogenesis in the retina and breast
Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., & Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90034-9 · Cited by 1,021
Wang, C.-Y., Cusack, J. C., Liu, R., & Baldwin, A. S. (1999) · Nature Medicine · doi:10.1038/7410 · Cited by 988
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
Li, Z.-W., Chu, W., Hu, Y., Delhase, M., Deerinck, T., Ellisman, M., Johnson, R., & Karin, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1839 · Cited by 926
Self-citationNeurath, M. F., Pettersson, S., Meyer Zum Büschenfelde, K.-H., & Strober, W. (1996) · Nature Medicine · doi:10.1038/nm0996-998 · Cited by 840
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 819
Transforming p21 Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions
Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A., & Pestell, R. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23589 · Cited by 803
Hinz, M., Krappmann, D., Eichten, A., Heder, A., Scheidereit, C., & Strauss, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2690 · Cited by 788
Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals
Giovannucci, E., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., & Willett, W. C. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-4-199408150-00001 · Cited by 785
Bargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H. D., Grinstein, E., Greiner, A., Scheidereit, C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119849 · Cited by 761
Fata, J. E., Kong, Y.-Y., Li, J., Sasaki, T., Irie-Sasaki, J., Moorehead, R. A., Elliott, R., Scully, S., Voura, E. B., Lacey, D. L., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00103-3 · Cited by 756
Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B
Wahl, C., Liptay, S., Adler, G., & Schmid, R. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci992 · Cited by 742
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G. J., Rogers, A. E., Traish, A. M., & Sonenshein, G. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119848 · Cited by 720
Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa
Rogler, G., Brand, K., Vogl, D., Page, S., Hofmeister, R., Andus, T., Knuechel, R., Baeuerle, P. A., Schölmerich, J., & Gross, V. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70202-1 · Cited by 715
Increased risk of large-bowel cancer in Crohn's disease with colonic involvement
Ekbom, A., Adami, H.-O., Helmick, C., & Zack, M. (1990) · The Lancet · doi:10.1016/0140-6736(90)91889-i · Cited by 699
Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.
Fantl, V, Stamp, G., Andrews, A., Rosewell, I., & Dickson, C. (1995) · Genes & Development · doi:10.1101/gad.9.19.2364 · Cited by 691
Rao, C. V., Rivenson, A., Simi, B., & Reddy, B. S. (1995) · PubMed · Cited by 676
Bcl10 Is Involved in t(1;14)(p22;q32) of MALT B Cell Lymphoma and Mutated in Multiple Tumor Types
Willis, T. G., Jadayel, D. M., Du, M.-Q., Peng, H., Perry, A. R., Abdul-Rauf, M., Price, H., Karran, L., Majekodunmi, O., Wlodarska, I., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80957-5 · Cited by 658
Plummer, S. M., Holloway, K. A., Manson, M. M., Munks, R. J., Kaptein, A., Farrow, S., & Howells, L. (1999) · Oncogene · doi:10.1038/sj.onc.1202980 · Cited by 628
Hanif, R., Pittas, A., Feng, Y., Koutsos, M. I., Qiao, L., Staiano-Coico, L., Shiff, S. I., & Rigas, B. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00181-5 · Cited by 608
Transcriptional Cross Talk between NF-κB and p53
Webster, G. A., & Perkins, N. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3485 · Cited by 598
Ruland, J., Duncan, G. S., Elia, A., del Barco Barrantes, I., Nguyen, L., Plyte, S., Millar, D. G., Bouchard, D., Wakeham, A., Ohashi, P. S., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00189-1 · Cited by 553
Boolbol, S. K., Dannenberg, A. J., Chadburn, A., Martucci, C., Guo, X., Ramonetti, J. T., Abreu-Goris, M., Newmark, H. L., Lipkin, M. L., DeCosse, J. J., et al. (1996) · PubMed · Cited by 545
Bond, M., Fabunmi, R. P., Baker, A. H., & Newby, A. C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01034-5 · Cited by 512
Sulindac Inhibits Activation of the NF-κB Pathway
Yamamoto, Y., Yin, M.-J., Lin, K.-M., & Gaynor, R. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27307 · Cited by 494
Cao, Y., Bonizzi, G., Seagroves, T. N., Greten, F. R., Johnson, R., Schmidt, E. V., & Karin, M. (2001) · Cell · doi:10.1016/s0092-8674(01)00599-2 · Cited by 482
Self-citationOhno, H. (1990) · Cell · doi:10.1016/0092-8674(90)90347-h · Cited by 456
Cogswell, P. C., Guttridge, D. C., Funkhouser, W. K., & Baldwin, A. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203412 · Cited by 452
Signaling Pathways in Mammary Gland Development
Hennighausen, L., & Robinson, G. W. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00064-8 · Cited by 422
Lucas, P. C., Yonezumi, M., Inohara, N., McAllister-Lucas, L. M., Abazeed, M. E., Chen, F. F., Yamaoka, S., Seto, M., & Núñez, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009984200 · Cited by 421
Farrow, D. C., Vaughan, T. L., Hansten, P. D., et al. (1998) · PubMed · Cited by 416
Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells
Keates, S., Hitti, Y., Upton, M., & Kelly, C. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9322504 · Cited by 414
The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis
Chung, D. C. (2000) · Gastroenterology · doi:10.1053/gast.2000.16507 · Cited by 414
A requirement for NF-kappa B activation in Bcr-Abl-mediated transformation
Reuther, J. Y., Reuther, G. W., Cortez, D., Pendergast, A. M., & Baldwin Jr., A. S. (1998) · Genes & Development · doi:10.1101/gad.12.7.968 · Cited by 392
Neri, A., Chang, C.-C., Lombardi, L., Salina, M., Corradini, P., Maiolo, A. T., Chaganti, R. S. K., & Dalla-Favera, R. (1991) · Cell · doi:10.1016/0092-8674(91)90285-7 · Cited by 390
Finco, T. S., Westwick, J. K., Norris, J. L., Beg, A. A., Der, C. J., & Baldwin, A. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24113 · Cited by 375
HER-2/neu Blocks Tumor Necrosis Factor-induced Apoptosis via the Akt/NF-κB Pathway
Zhou, B. P., Hu, M. C.-T., Miller, S. A., Yu, Z., Xia, W., Lin, S.-Y., & Hung, M.-C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.8027 · Cited by 371
Huang, S., Robinson, J. B., DeGuzman, A., Bucana, C. D., & Fidler, I. J. (2000) · PubMed · Cited by 369
Akagi, T., Motegi, M., Tamura, A., Suzuki, R., Hosokawa, Y., Suzuki, H., Ota, H., Nakamura, S., Morishima, Y., Taniwaki, M., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1203018 · Cited by 346
Inhibition of NF-κB induces apoptosis of KSHV-infected primary effusion lymphoma cells
Keller, S. A., Schattner, E. J., & Cesarman, E. (2000) · Blood · doi:10.1182/blood.v96.7.2537 · Cited by 315
The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators
Dechend, R., Hirano, F., Lehmann, K., Heissmeyer, V., Ansieau, S., Wulczyn, F. G., Scheidereit, C., & Leutz, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202717 · Cited by 312
Elevated cyclooxygenase-2 levels in Min mouse adenomas
Williams, C., Luongo, C., Radhika, A., Zhang, T., Lamps, L., Nanney, L., Beauchamp, R., & DuBois, R. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70083-5 · Cited by 303
Weber, C. K., Liptay, S., Wirth, T., Adler, G., & Schmid, R. M. (2000) · Gastroenterology · doi:10.1053/gast.2000.19458 · Cited by 299
Xiao, G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.23.6805 · Cited by 294
Modulation of NF-κB Activity and Apoptosis in Chronic Lymphocytic Leukemia B Cells
Furman, R. R., Asgary, Z., Mascarenhas, J. O., Liou, H.-C., & Schattner, E. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.2200 · Cited by 278
Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells
Krappmann, D., Emmerich, F., Kordes, U., Scharschmidt, E., Dörken, B., & Scheidereit, C. (1999) · Oncogene · doi:10.1038/sj.onc.1202351 · Cited by 271
Nuclear factor-κB is upregulated in colorectal cancer
Lind, D. S., Hochwald, S. N., Malaty, J., Rekkas, S., Hebig, P., Mishra, G., Moldawer, L. L., Copeland, E. M., & MacKay, S. (2001) · Surgery · doi:10.1067/msy.2001.116672 · Cited by 269
Pianetti, S., Arsura, M., Romieu-Mourez, R., Coffey, R. J., & Sonenshein, G. E. (2001) · Oncogene · doi:10.1038/sj.onc.1204257 · Cited by 265
NF-κB inhibition causes spontaneous apoptosis in Epstein–Barr virus-transformed lymphoblastoid cells
Cahir-McFarland, E. D., Davidson, D. M., Schauer, S. L., Duong, J., & Kieff, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100119497 · Cited by 259
Pereira, M. A., Grubbs, C. J., Barnes, L. H., Li, H., Olson, G. R., Eto, I., Juliana, M., Whitaker, L. M., Kelloff, G. J., Steele, V. E., et al. (1996) · Carcinogenesis · doi:10.1093/carcin/17.6.1305 · Cited by 246
RelB Cellular Regulation and Transcriptional Activity Are Regulated by p100
Solan, N. J., Miyoshi, H., Carmona, E. M., Bren, G. D., & Paya, C. V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109619200 · Cited by 224
Egan, L. J., Mays, D. C., Huntoon, C. J., Bell, M. P., Pike, M. G., Sandborn, W. J., Lipsky, J. J., & McKean, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26448 · Cited by 217
REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma
Houldsworth, J., Mathew, S., Rao, P., Dyomina, K., Louie, D., Parsa, N., Offit, K., & Chaganti, R. (1996) · Blood · doi:10.1182/blood.v87.1.25.25 · Cited by 211
Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel
Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203222 · Cited by 200
Methotrexate Suppresses NF-κB Activation Through Inhibition of IκBα Phosphorylation and Degradation
Majumdar, S., & Aggarwal, B. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2911 · Cited by 192
Chronic intestinal inflammation: An unexpected outcome in cytokine or T cell receptor mutant mice
Strober, W., & Ehrhardt, R. O. (1993) · Cell · doi:10.1016/0092-8674(93)80062-j · Cited by 188
Yamaoka, S., Inoue, H., Sakurai, M., Sugiyama, T., Hazama, M., Yamada, T., & Hatanaka, M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00422.x · Cited by 183
Ishikawa, H., Carrasco, D., Claudio, E., Ryseck, R.-P., & Bravo, R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.999 · Cited by 176
Biswas, D. K., Dai, S.-C., Cruz, A., Weiser, B., Graner, E., & Pardee, A. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151257998 · Cited by 170
Madry, C. (1998) · International Immunology · doi:10.1093/intimm/10.11.1693 · Cited by 168
Wang, W., Abbruzzese, J. L., Evans, D. B., & Chiao, P. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202833 · Cited by 161
Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells
Kim, D. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.871 · Cited by 160
Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.
Romieu, R., Landesman‐Bollag, E., Seldin, D. C., Traish, A. M., Mercurio, F., & Sonenshein, G. E. (2001) · PubMed · Cited by 159
Takeshita, H., Yoshizaki, T., Miller, W. E., Sato, H., Furukawa, M., Pagano, J. S., & Raab‐Traub, N. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5548-5555.1999 · Cited by 127
Dejardin, E., Bonizzi, G., Bellahcène, A., Castronovo, V., Merville, M.-P., & Bours, V. (1995) · PubMed · Cited by 124
NF-κB Inhibits Apoptosis in Murine Mammary Epithelia
Clarkson, R. W. E., Heeley, J. L., Chapman, R. S., Aillet, F., Hay, R. T., Wyllie, A. H., & Watson, C. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12737 · Cited by 112
Hardwick, J. C. H., van den Brink, G. R., Offerhaus, G. J. A., van Deventer, S. J. H., & Peppelenbosch, M. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204162 · Cited by 106
Migliazza, A., Lombardi, L. T., Rocchi, M., Trecca, D., Chang, C. M., Antonacci, R., Fracchiolla, N., Ciana, P., Maiolo, A. T., & Neri, A. (1994) · Blood · doi:10.1182/blood.v84.11.3850.bloodjournal84113850 · Cited by 104
Caamaño, J., Pérez, P., Lira, S. A., & Bravo, R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1342 · Cited by 100
McKay, B. C., Becerril, C., & Ljungman, M. E. (2001) · Oncogene · doi:10.1038/sj.onc.1204901 · Cited by 98
Zucca, E., Roggero, E., & Pileri, S. A. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00513.x · Cited by 97
Alterations at the rel locus in human lymphoma.
Lu, D., Thompson, J. D., Gk, G., et al. (1991) · PubMed · Cited by 90
Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel
Gilmore, T. D., Cormier, C., Jean-Jacques, J., & Gapuzan, M.-E. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204898 · Cited by 88
The Role of Epstein-Barr Virus in Neoplastic Transformation
Knecht, H., Berger, C., Rothenberger, S., Odermatt, B. F., & Brousset, P. (2001) · Oncology · doi:10.1159/000058523 · Cited by 79
Kim, H., Lim, J. W., & Kim, K. H. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655201300191969 · Cited by 73
Taketo, M. M. (1998) · Inflammation Research · doi:10.1007/s000110050295 · Cited by 71
Tang, R., Wang, J., Lo, S. K., & Hsieh, L. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990812)82:4<473::aid-ijc1>3.0.co;2-k · Cited by 70
Cited by
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Self-citationNF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
Self-citation
Metadata
- Authors
- Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W.
- Venue
- Nature Reviews Cancer
- Published
- 2002-04
- Volume
- 2
- Issue
- 4
- Pages
- 301-310
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2007456673
- Cited by
- 2,478
- References
- 99
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.